Dogwood Therapeutics (DWTX) Set to Announce Earnings on Thursday

Dogwood Therapeutics (NASDAQ:DWTX) will be releasing its earnings data before the market opens on Thursday, November 7th. Analysts expect Dogwood Therapeutics to post earnings of ($1.33) per share for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.

Dogwood Therapeutics (NASDAQ:DWTX) last issued its earnings results on Thursday, August 8th. The company reported ($1.25) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($1.75) by $0.50. On average, analysts expect Dogwood Therapeutics to post $-5 EPS for the current fiscal year and $-4 EPS for the next fiscal year.

Dogwood Therapeutics Trading Down 0.5 %

Shares of DWTX stock traded down $0.02 during mid-day trading on Tuesday, reaching $4.42. 23,578 shares of the stock traded hands, compared to its average volume of 51,934. Dogwood Therapeutics has a 1-year low of $2.50 and a 1-year high of $26.00. The firm has a market capitalization of $4.91 million, a price-to-earnings ratio of -0.74 and a beta of 1.57.

Dogwood Therapeutics Company Profile

Virios Therapeutics, Inc, a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company’s lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia.